Log In
Print
BCIQ
Print
Print this Print this
 

LJPC-401

  Manage Alerts
Collapse Summary General Information
Company La Jolla Pharmaceutical Co.
DescriptionSynthetically derived hepcidin, an endogenous hormone that regulates iron absorption
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAnemia
Indication DetailsTreat transfusion-dependent anemia and severe chronic iron overload in patients who are refractory or intolerant to chelation therapy
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today